194 related articles for article (PubMed ID: 10497186)
1. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
2. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
3. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
4. Involvement of a calcium-independent pathway in plasmin-induced platelet shape change.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Life Sci; 2001 Jul; 69(8):945-60. PubMed ID: 11488407
[TBL] [Abstract][Full Text] [Related]
5. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.
Bauer M; Retzer M; Wilde JI; Maschberger P; Essler M; Aepfelbacher M; Watson SP; Siess W
Blood; 1999 Sep; 94(5):1665-72. PubMed ID: 10477691
[TBL] [Abstract][Full Text] [Related]
6. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation.
Wilde JI; Retzer M; Siess W; Watson SP
Platelets; 2000 Aug; 11(5):286-95. PubMed ID: 11030463
[TBL] [Abstract][Full Text] [Related]
7. Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin.
Retzer M; Siess W; Essler M
FEBS Lett; 2000 Jan; 466(1):70-4. PubMed ID: 10648815
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
Amobi NI; Chung IP; Smith IC
Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
[TBL] [Abstract][Full Text] [Related]
9. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
Dorsam RT; Kim S; Jin J; Kunapuli SP
J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Hardy AR; Hill DJ; Poole AW
Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulation of platelets rapidly induces Ca2+-dependent dephosphorylation of cofilin that is independent of dense granule secretion and aggregation.
Pandey D; Goyal P; Siess W
Blood Cells Mol Dis; 2007; 38(3):269-79. PubMed ID: 17321765
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.
Retzer M; Essler M
Cell Signal; 2000 Oct; 12(9-10):645-8. PubMed ID: 11080616
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide.
Missy K; Plantavid M; Pacaud P; Viala C; Chap H; Payrastre B
Thromb Haemost; 2001 Mar; 85(3):514-20. PubMed ID: 11307824
[TBL] [Abstract][Full Text] [Related]
15. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase.
Mita M; Yanagihara H; Hishinuma S; Saito M; Walsh MP
Biochem J; 2002 Jun; 364(Pt 2):431-40. PubMed ID: 12023886
[TBL] [Abstract][Full Text] [Related]
16. The neutrophil serine protease PR3 induces shape change of platelets via the Rho/Rho kinase and Ca(2+) signaling pathways.
Peng X; Ramström S; Kurz T; Grenegård M; Segelmark M
Thromb Res; 2014 Aug; 134(2):418-25. PubMed ID: 24993595
[TBL] [Abstract][Full Text] [Related]
17. Trypsin causes platelet activation independently of known protease-activated receptors.
Mao Y; Kunapuli SP
Thromb Haemost; 2013 Dec; 110(6):1241-9. PubMed ID: 24030758
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.
Watanabe Y; Ito M; Kataoka Y; Wada H; Koyama M; Feng J; Shiku H; Nishikawa M
Blood; 2001 Jun; 97(12):3798-805. PubMed ID: 11389019
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum.
Swärd K; Dreja K; Susnjar M; Hellstrand P; Hartshorne DJ; Walsh MP
J Physiol; 2000 Jan; 522 Pt 1(Pt 1):33-49. PubMed ID: 10618150
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of high K+-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway.
Sakamoto K; Hori M; Izumi M; Oka T; Kohama K; Ozaki H; Karaki H
J Pharmacol Sci; 2003 May; 92(1):56-69. PubMed ID: 12832856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]